Diagnostic cerebral angiography Signs and Symptoms
Conditions
Interventions
We randomly assigned 61 patients to receive propofol-based PCS (n = 33, 15 mg bolus in 9 s) or placebo-based PCS (n = 28, bolus of 1.5 mL of a 20% lipid emulsion in 9 s).
Sponsors
Assistance Publique ? Hôpitaux de Marseille AP-HM (France)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age under 70 years 2. ASA physical status below 3 3. Scheduled cerebral angiography 4. Consultation with an anesthetist at least 48 hours before the procedure
Exclusion criteria
Exclusion criteria: 1. Age under 18 years, 2. Emergency context 3. History of psychiatric disease 4, Long-course anxiolytic treatment 5. Counter-indication to propofol 6. Withdrawal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main objective was to evaluate whether a propofol-based PCS would lead at least to 20% difference in patients? satisfaction on the EVAN scale, which was self reported the day after the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives were to assess the quality of patient conditioning by the neuroradiologist and the anesthetist and to report possible side effect. | — |
Countries
France
Outcome results
None listed